CDC: Updated booster reduces COVID-19 risk for nursing home residents

Jan 26, 2023 - 04:05 PM
An elderly woman is escorted by a younger woman who has her arm around the shoulders of the elderly woman, viewed from behind.

Between Oct. 10, 2022, and Jan. 8, 2023, nursing home residents who were not up to date with the recommended COVID-19 vaccinations had a 30%-50% higher risk for SARS-CoV-2 infection than residents who were up to date, according to a study released today by the Centers for Disease Control and Prevention. New COVID-19 cases among residents who received a bivalent booster in the past two months (or a primary series and monovalent booster if they were not yet eligible) ranged from 7.2 to 15.6 per 1,000, compared with 9.5 to 18.8 per 1,000 for residents whose vaccinations were not up to date. By Jan. 8, about 49% of residents were up to date with the recommended COVID-19 vaccinations.  

“Nursing home residents can maximize protection against COVID-19 by receiving bivalent COVID-19 booster doses to stay up to date with recommended COVID-19 vaccinations,” the authors conclude.

In a second and ongoing study of nursing and veterans homes in Ohio and Rhode Island, SARS-CoV-2 antibody levels waned within two months after receiving a monovalent booster, but a bivalent booster restored immunity and broadened antibody response.
 

Related News Articles

Headline
NASEM releases evidence review on COVID-19 vaccine safety
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
FDA approves combo test for flu, COVID-19; alerts providers to medical device risks 
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
CDC recommends additional dose of updated COVID-19 vaccine for older adults
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
FDA: Paxlovid no longer labeled for emergency use after March 8
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
CDC study finds low rates of COVID-19, flu and RSV vaccinations in adults 
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…
Headline
NIH test-to-treat telehealth program goes national, covers both COVID-19 and flu 
The Home Test to Treat program now offers free testing, telehealth and treatment for both COVID-19 and flu to eligible adults nationwide, the National…